SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy.

Higham, C E; Olsson-Brown, A; Carroll, P; Cooksley, T; Larkin, J; Lorigan, P; Morganstein, D; Trainer, P J

Higham, C E; Olsson-Brown, A; Carroll, P; Cooksley, T; Larkin, J; Lorigan, P; Morganstein, D; Trainer, P J.

Afiliação

Higham CE; Department of EndocrinologyChristie Hospital NHS Foundation Trust, Manchester, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK claire.higham@christie.nhs.uk.
Olsson-Brown A; The Clatterbridge Cancer CentreBebbington, Wirral, UK.
Carroll P; The University of LiverpoolBrownlow Hill, Liverpool, UK.
Cooksley T; Department of EndocrinologyGuy's & St. Thomas' NHS Foundation Trust, London, UK.
Larkin J; Department of Acute MedicineUHSM and Christie Hospital NHS Foundation Trust, Manchester, UK.
Lorigan P; Skin UnitRoyal Marsden Hospital, London, UK.
Morganstein D; Department of Medical OncologyChristie Hospital NHS Foundation Trust, Manchester, UK.
Trainer PJ; Department of EndocrinologyChelsea and Westminster Hospital, London, UK.

Endocr Connect ; 7(7): G1-G7, 2018 Jul.

Article em En | MEDLINE | ID: mdl-29930025

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Endocr Connect Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google